Results 191 to 200 of about 555,429 (217)

What are the views of cancer care administrators and clinicians in England on the use of a machine learning clinical decision support system (ML-CDSS) to predict patients' risk of hepatic and renal deterioration during chemotherapy? A qualitative study. [PDF]

BMJ Open
Ercia A, Yip M, Reed C, Steventon L, Geoghegan C, Watson M, Kennelly C, Chambers P, Al Moubayed N.   +8 more
europepmc   +1 more source

Belzutifan efficacy in von Hippel-Lindau disease-associated renal cell carcinoma versus natural history control arm. [PDF]

J Natl Cancer Inst
Linehan WM, Jemielita T, Cornell J, Chen K, Ball MW, Srinivasan R, Liu Y, Perini RF, Pinto CA.   +8 more
europepmc   +1 more source

Not all masses are metastases: a diagnostic dilemma resolved - synchronous HER2-positive breast cancer and renal oncocytoma. [PDF]

Int J Surg Case Rep
Shrivastava N, Mitra S, Pande S.
europepmc   +1 more source

Quantitative Diffusion-weighted Imaging in Eosinophilic Solid and Cystic Renal Cell Carcinoma. [PDF]

Radiol Imaging Cancer
Glessgen CG, Tille JC, Benamran D, Thoeny HC.   +3 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

An interdisciplinary consensus on the management of brain metastases in patients with renal cell carcinoma

Ca-A Cancer Journal for Clinicians, 2022
Marion Smits, Jeffrey S Weinberg, James Yu   +2 more
exaly  

Treatment of renal cell carcinoma: Current status and future directions

Ca-A Cancer Journal for Clinicians, 2017
, Pedro C Barata
exaly  

Current management of renal cell carcinoma

Ca-A Cancer Journal for Clinicians, 1996
Arie Belldegrun, J B Dekernion, R A Figlin   +2 more
exaly